Table 2. Outcomes Table Assumptions
| Benefits and Harms |
Condition (reference) |
This Review
RR or OR (95% CI) |
Results of WHI*
HR (95% CI) |
Incidence or Mortality Rates by Age Group |
| 55-64 |
65-74 |
75-84 |
| 55-59 |
60-64 |
65-69 |
70-74 |
75-79 |
80-84 |
| Benefits |
Hip fracture23 |
0.76 (0.56-1.01) |
0.66 (0.33-1.33) |
0.00089 |
0.001528 |
0.002372 |
0.005305 |
0.010184 |
0.017315 |
| Wrist fracture24 |
0.44 (0.23-0.84) |
NA |
0.006053 |
0.00671 |
0.008113 |
| Vertebral fracture25 |
0.60 (0.36-0.99) |
0.66 (0.32-1.34) |
0.0068 |
0.0093 |
0.0123 |
0.0161 |
0.0205 |
0.0252 |
| Colorectal cancer27 |
0.80 (0.74-0.86) |
0.63 (0.32-1.24) |
0.000712 |
0.001121 |
0.001568 |
0.002274 |
0.002951 |
0.003838 |
| Uncertain Benefits |
Dementia incidence26 |
0.66 (0.53-0.82) |
NA |
0.005** |
0.01 |
0.02** |
| Harms |
Coronary heart disease incidence22 |
0.91 (0.67-1.33) |
1.29 (1.02-1.63) |
0.00174 |
0.00264 |
0.00308 |
0.00398** |
| Overall stroke incidence22 |
1.12 (1.01-1.23) |
1.41 (0.66-2.31) |
0.00064* |
0.00121 |
0.00229 |
0.00469** |
Thromboembo-
lism incidence (1 <year)29 |
3.49 (2.33-5.59) |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
Thromboembo-
lism incidence (overall)29 |
2.14 (1.64-2.81) |
2.11 (1.26-3.55) |
0.00013 |
0.00013 |
0.00013 |
| Breast cancer incidence (<5 years)27
|
1.0 - 1.14 |
NA |
0.002963 |
0.003473 |
0.004044 |
0.004555 |
0.004833 |
0.004681 |
| Breast cancer incidence (>5 years)27 |
1.23 - 1.35 |
1.26 (1.00-1.59) |
0.002963 |
0.003473 |
0.004044 |
0.004555 |
0.004833 |
0.004681 |
| Cholecystitis (<5 years)28 |
1.8 (1.6-2.0) |
NA |
0.00357 |
0.00357 |
0.00357 |
| Cholecystitis (>5 years)28 |
2.5 (2.0-2.9) |
NA |
0.00357 |
0.00357 |
0.00357 |
*Nominal CIs are indicated for main outcomes of the trial (breast cancer, CHD), adjusted CIs for secondary outcomes.
**Data based on extrapolated values.
Note: NA indicates not available; WHI, Women's Health Initiative.
Return to Document